SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+20.31%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$754M
AUM Growth
+$754M
(+25%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
48.98%
Holding
104
New
23
Increased
22
Reduced
27
Closed
20
Top Buys
| 1 |
Sanofi
SNY
|
$22.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$21.3M |
| 3 |
Novartis
NVS
|
$18.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11.4M |
| 5 |
Viatris
VTRS
|
$11.3M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$35.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$24.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$13.9M |
| 4 |
Gilead Sciences
GILD
|
$13M |
| 5 |
Bristol-Myers Squibb
BMY
|
$12.5M |
Sector Composition
| 1 | Healthcare | 84.32% |
| 2 | Technology | 10.06% |
| 3 | Industrials | 1.58% |
| 4 | Consumer Discretionary | 1.5% |
| 5 | Communication Services | 0.73% |